Introduction: Berger’s disease is a kidney related disorder which occurs due to accumulation of antibody IgA in the kidneys. This accumulation leads to kidney damage that inturn leads to decrease in the efficiency of functioning of kidney ultimately causing renal failure. Hence, it is also called as IgA nephropathy.
Symptoms: There may not be any symptoms in early stage and may go unnoticed for a long period of time. In severe conditions change in colour of urine or visible blood in the urine, pain in the back below the ribs, foam in the urine, hypertension, swelling of hands and feet may be observed.
Statistics: Death rate in netherlands due to renal diseases is 5.50 with 1,877 deaths that accounts for 1.81% of total deaths.
Treatment: There is no cure for Berger’s disease .Depending on the symptoms doctor may prescribe medications to suppress immune system, control hypertension, reduce swelling in the body. The main idea is to slow down the rate of damage of kidneys. People with renal failure may need dialysis or may undergo kidney transplant.
Research: Currently researcher is being made to discover the molecular pathway that causes kidney damage, and suggest targets for drug development.
Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: Systematic review and meta-analysis PPT Version |
Metalloproteinases and their inhibitors gene expression profiles in leukocytes of primary hypertension (PH), non-alcoholic fatty liver disease (NAFLD), and obese children PPT Version |
Depressive symptoms among older adults with mild to moderate Knee osteoarthritis are highly prevalent and are predicted by disease management self-efficacy: A cross-sectional study of depressive symptom prevalence, and clinical interrelationships PPT Version |
Tracking of viral evolution during an outbreak of emerging beak and feather disease virus (BFDV) infection in the critically endangered Orange-bellied parrot (Neophema chrysogaster) PPT Version |